AzTrials
AzTrials

Paediatric Outpatient SurgeryPhase 3IPADNCT02192710

Reduction of Preoperative Anxiety in Children: Electronic Tab vs Midazolam

A Phase 3 study testing electronic tab and Midazolam oral intake in people with Paediatric Outpatient Surgery, run by Hospices Civils de Lyon at 1 site in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Rationale: The most frequently used means to prevent pre-anaesthetic anxiety in children is a drug premedication. Midazolam, a benzodiazepine, is mainly used. It requires time for action, so coordination between departments and operating room, exposed to the risks of side effects and failure and this variability… Read more about this study

Who is it for?
Ages 4 to 10 years
Conditions the study is for
Paediatric Outpatient Surgery
What is being tested?
electronic tab and Midazolam oral intake
Could I receive a placebo?
No, everyone receives an active treatment
How many people
118 participants
Where
1 siteFrance
Study dates
May 2013to Apr 2014
Phase
Phase 3
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 4 to 10 years
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • Girls and boys aged 4 to 10 years,
  • American Society of Anesthesiologists Score between 1 and 3,
  • programmed outpatient surgery for a short term and low level of pain
  • Infection with influenza A virus confirmed with a quick diagnostic test,
  • informed consent from both parents

Who cannot join

  • patients younger than 4 or older than 10 years old
  • preexisting psychiatric disorder with pedo-psychiatric follow-up
  • children with intellectual disability
  • psychotropic referred to anxiolytic and / or antipsychotic
  • history of surgery (n>=3)
  • refusal to participate

Trial locations and contacts

1 site in 1 country.

France1 site
  • Service d'anesthésie, Hôpital Femme Mère Enfant, Hospices Civils de Lyon

    Bron, 69500

Other trials in France

About this study

Rationale:

The most frequently used means to prevent pre-anaesthetic anxiety in children is a drug premedication. Midazolam, a benzodiazepine, is mainly used. It requires time for action, so coordination between departments and operating room, exposed to the risks of side effects and failure and this variability action. Alternative means were evaluated, such as the presence of parents during anaesthetic mask induction, distraction by clowns, hypnosis or video games.

Read more

Electronic tabs are small devices; light, easy to use with age-specific and interactive programs. Our hypothesis is that these electronic tabs are more effective in reducing anxiety and distract children compare to preoperative medication.

Methods: This is a monocentric, randomized, open-label study comparing patients aged 4 to 10 years old programmed for a short term and low level of pain outpatient surgery. My pass score will be measured when arriving at the hospital, at the time of the separation with the parents, at the time of the anaesthetic mask induction and after the surgery.

118 patients will be randomized as follows :

  • Arm 1 : Hypnovel® (midazolam)
  • Arm 2 : Electronic tab The recruitment is performed by general practitioners in the Lyon area.
Being tested
electronic tab, Midazolam oral intake
Keywords
outpatient surgery, anaesthesia, midazolam, electronic tab

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • electronic tabProcedure or surgery

    classic use of an electronic tab with age specific games

  • Midazolam oral intakeDrug

Study groups in NCT02192710
Study groupRoleWhat they receive
Hypnovel® (midazolam)Active comparatorMidazolam oral intake before anesthesia
Receives: Drug: Midazolam oral intake
Electronic tabExperimentalNot described
Receives: Procedure: electronic tab

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Patient's level of anxiety

    Comparison of m-YPAS score between the 2 arms at the time of anaesthetic mask induction (H0)

    Measured: at day 1

Secondary outcomes (4)
  1. Patient's level of anxiety

    Comparison of m-YPAS score between the 2 arms

    • when arriving at the operating room airlock H-1 before surgery,
    • at the time of the separation with the parents
    • 15 minutes before surgery and
    • 30 minutes before departure from the hospital the same day

    Measured: At day 1

  2. Parents' level of anxiety

    Evaluation of parents anxiety will be assessed by State-Trait Anxiety Inventory (STAI) :

    • when arriving at the operating room airlock H-1 before surgery,
    • at the time of the separation with the parents
    • 15 minutes before surgery and
    • 30 minutes before departure from the hospital the same day

    Measured: At Day 1

  3. Parents' level of anxiety

    post-surgery behavioral changes will be measured using the Post Hospitalization Behavioral Questionnaire (PHBQ) at Day+1, day+7 and Day+14 after surgery

    Measured: Up to 2 weeks after Day 1

  4. Satisfaction of patients, parents and medical team

    Evaluation of the general satisfaction of children, parents and anesthetic staff will be measured using Visual Analogic Scale (VAS) 30 minutes before departure from the hospital the same day

    Measured: at day 1

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted17 Jul 2014 (estimated)
  2. Study startMay 2013
  3. Primary completionApr 2014
  4. Study completionApr 2014

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 3
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
118 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02192710
Sponsor's protocol ID
2013.794
Acronym
IPAD
Status last verified
Dec 2025
First submitted
25 Apr 2014
Last updated
19 Dec 2025
Results posted
No
Data monitoring committee
No

Publications

  • Marechal C, Berthiller J, Tosetti S, Cogniat B, Desombres H, Bouvet L, Kassai B, Chassard D, de Queiroz Siqueira M. Children and parental anxiolysis in paediatric ambulatory surgery: a randomized controlled study comparing 0.3 mg kg-1 midazolam to tablet computer based interactive distraction. Br J Anaesth. 2017 Feb;118(2):247-253. doi: 10.1093/bja/aew436.

    PubMed 28100529

Questions about this trial

What is this clinical trial studying?

A Phase 3 study testing electronic tab and Midazolam oral intake in people with Paediatric Outpatient Surgery, run by Hospices Civils de Lyon at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 19 Dec 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Phase 3 studies compare the treatment with the current standard treatment or a placebo in a large group, to confirm how well it works and watch for side effects.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Patient's level of anxiety (time frame: at day 1). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02192710, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 Dec 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in